Retinoic acid receptor (RAR ) plays an important role in mediating all-trans retinoic acid (ATRA) signals. In this study, we found that ATRA up-regulated RAR mRNA and protein expression in gastric cancer BGC-823 cells. However, in breast cancer MCF-7 cells it down-regulated RAR protein expression with no effect on its RAR mRNA. Immunoprecipitation/Western blot analysis showed that, although sumoylated and ubiquitinated RAR existed simultaneously in both cancer cell lines, ATRA exerted different regulatory effects on sumoylation and ubiquitination of RAR . In MCF-7 cells, ATRA treatment enhanced the ubiquitination of RAR and the subsequent degradation of RAR through the ubiquitin/proteasome pathway. This resulted in a reduction in the DNA binding activity of RAR /retinoid X receptor (RXR ) heterodimer, the separation of RXR from RAR and the translocation of RXR from the nucleus to the cytoplasm. By contrast, in BGC-823 cells, ATRA augmented sumoylation, not ubiquitination, of RAR . The stability of sumoylated RAR was significantly stronger than in non-sumoylated RAR . These results also showed an increase in the DNA binding activity of the RAR /RXR heterodimer and the stability of nuclear localization of this heterodimer, which normally facilitates the ATRA signal transduction. In conclusion, our results reveal a novel mechanism for the regulation of RAR -dependent signal transduction through the ubiquitin/proteasome pathway in breast cancer cells and the sumoylation pathway in gastric cancer cells.